<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03771508</url>
  </required_header>
  <id_info>
    <org_study_id>MDT18014</org_study_id>
    <nct_id>NCT03771508</nct_id>
  </id_info>
  <brief_title>Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments (SODA)</brief_title>
  <acronym>SODA</acronym>
  <official_title>PillCam SB3 Registry for Development and Validation of Improved Algorithms for GI Pathologies Detection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic - MITG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic - MITG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Observational, Multicenter, Post-market, Minimal risk, Prospective data collection of PillCam
      SB3 videos (including PillCam reports) and raw data files.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to 5000 PillCam SB3 videos (including PillCam reports) and raw data files will be
      collected in up to 25 medical centers in the US. Study duration is up to 3 years from IRB
      approval.

      Medical center study sites will provide relevant videos (including PillCam reports) and raw
      data from patients who underwent SB3 procedures. Study subjects will not undergo any
      additional procedures, nor will their diagnosis and subsequent treatment pathway be changed
      for the purpose of the registry.

      The data will be used by MDT GIs research and development team for the development and
      validation of improved and new detectors in the PillCam software.

      The videos (including PillCam reports) and raw data files will be de-identified at the
      medical center by representatives who are authorized and delegated to review medical records,
      prior to providing them to the sponsor. Videos, reports and raw data files will be
      de-identified in a manner that is untraceable by the sponsor clinical study team members.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2018</start_date>
  <completion_date type="Anticipated">January 2021</completion_date>
  <primary_completion_date type="Anticipated">January 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prospective collection of PillCam SB3 videos</measure>
    <time_frame>2 years</time_frame>
    <description>sponsor database will be expanded with images of pathologies and normal mucosa for future development and validation of improved algorithms for GI pathologies detection with the PillCam platform</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Small Intestine Disease</condition>
  <condition>Small Intestine Cancer</condition>
  <condition>Small Intestinal Ulcer Bleeding</condition>
  <condition>Small Intestine Obstruction</condition>
  <condition>Small Intestine Adenocarcinoma</condition>
  <condition>Small Intestine Polyp</condition>
  <arm_group>
    <arm_group_label>PillCam SB3 procedure</arm_group_label>
    <description>Subjects with normal/abnormal PillCam SB3 procedure</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent Standard of Care SB3 procedure
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All SB3 cases collected during standard of care procedures.

          -  The subject received an explanation and understands the nature of the study and
             provided oral consenting

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Roslana Fox</last_name>
    <phone>972-2355303</phone>
    <email>roslana.fox@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tirza David</last_name>
    <email>tirza.david@medtronic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Birmingham Gastroenterology Associates</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sara Ingles</last_name>
      <phone>205-271-8000</phone>
      <email>single@bgapc.com</email>
    </contact>
    <investigator>
      <last_name>Charles Bluhm, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Research Center of Connecticut</name>
      <address>
        <city>Hamden</city>
        <state>Connecticut</state>
        <zip>06518</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Nikolich</last_name>
      <email>jnikolich@gastrocenter.org</email>
    </contact>
    <investigator>
      <last_name>David Hass</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Encore Borland-Groover</name>
      <address>
        <city>Jacksonville</city>
        <state>Florida</state>
        <zip>32256</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cynthia Buda</last_name>
      <phone>904-680-0871</phone>
    </contact>
    <investigator>
      <last_name>Mark Fleisher, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivia Price</last_name>
      <phone>913-588-3934</phone>
    </contact>
    <investigator>
      <last_name>Tuba Esfandyari, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UMass Memorial Health Care</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anne Foley</last_name>
      <phone>774-442-4098</phone>
      <email>Anne.Foley@umassmemorial.org</email>
    </contact>
    <investigator>
      <last_name>David Cave, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlantic Digestive Health Institute</name>
      <address>
        <city>Morristown</city>
        <state>New Jersey</state>
        <zip>07960</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Rondon</last_name>
      <email>Nicole.Rondon@atlantichealth.org</email>
    </contact>
    <investigator>
      <last_name>Razvan Arsenescu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwell Health - Cohen Children's Medical Center of New York</name>
      <address>
        <city>Lake Success</city>
        <state>New York</state>
        <zip>11042</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aditya A. Bissoonauth</last_name>
      <email>abissoonau@northwell.edu</email>
    </contact>
    <investigator>
      <last_name>Samuel Bitton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diana Burke</last_name>
      <email>diana.burke@osumc.edu</email>
    </contact>
    <investigator>
      <last_name>Madalina Butnariu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Digestive Disease Specialists Inc</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margaret Freede</last_name>
      <phone>405-702-1246</phone>
      <email>mfreede@okddsi.net</email>
    </contact>
    <investigator>
      <last_name>Kenneth Seres, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Thomas Jefferson University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Matthews</last_name>
      <email>Michael.Matthews@jefferson.edu</email>
    </contact>
    <investigator>
      <last_name>David Kastenberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>December 7, 2018</study_first_submitted>
  <study_first_submitted_qc>December 7, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 11, 2018</study_first_posted>
  <last_update_submitted>June 4, 2020</last_update_submitted>
  <last_update_submitted_qc>June 4, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Intestinal Neoplasms</mesh_term>
    <mesh_term>Intestinal Obstruction</mesh_term>
    <mesh_term>Intestinal Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Patient data will not be shared.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

